S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
3rd Massive Dollar Upheaval Has Started (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
3rd Massive Dollar Upheaval Has Started (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
3rd Massive Dollar Upheaval Has Started (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
S&P 500   4,140.06
DOW   32,832.54
QQQ   320.71
How to Use the MarketBeat Dividend Calculator
MUST WATCH: Unusual 3-second financial maneuver (Ad)
Two Appealing Biotech Stocks for Two Distinct investors
Is Tyson Foods A Buy On Post-Earnings Weakness? 
Pfizer buying spree continues with $5.4B hematology deal
3rd Massive Dollar Upheaval Has Started (Ad)
Nuclear plant in Ukraine is shelled; Rising dangers feared
Is DoorDash Ready To Sprint Higher? 
Closing prices for crude oil, gold and other commodities
Biden & Bill Gates Igniting $40 Trillion Heist? (Ad)
NASDAQ:MCHX

Marchex - MCHX Stock Forecast, Price & News

$2.06
+0.02 (+0.98%)
(As of 08/8/2022 12:00 AM ET)
Add
Compare
Today's Range
$1.76
$2.10
50-Day Range
$1.26
$2.09
52-Week Range
$1.23
$3.63
Volume
55,970 shs
Average Volume
30,162 shs
Market Capitalization
$87.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Marchex MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
94.2% Upside
$4.00 Price Target
Short Interest
Healthy
0.44% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.21mentions of Marchex in the last 14 days
Based on 6 Articles This Week
Insider Trading
Acquiring Shares
$15,078 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.11) to ($0.09) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Computer And Technology Sector

301st out of 833 stocks

Business Services, Not Elsewhere Classified Industry

49th out of 136 stocks

MCHX stock logo

About Marchex (NASDAQ:MCHX) Stock

Marchex, Inc. operates as an analytics and solutions company that helps businesses connect, drive, measure, and convert callers into customers in the United States and Canada. Its products include Marchex Call Analytics, an analytics platform for enterprises, which depend on inbound phone calls to drive sales, appointments, and reservations; Marchex Call Analytics, Conversation Edition that enable actionable insights for enterprise, mid-sized, and small businesses; Text Analytics and Communications, a solution for intelligent mobile messaging, which enables sales, marketing, and operations teams in businesses to engage in two-way communications with field staff, prospects, and customers through text/SMS messages; Call Monitoring for call recording; and Marchex Marketing Edge, an analytics solution for marketers in enterprise, mid-sized and small businesses that depend on inbound phone calls to drive sales, appointments and reservations. The company's Marchex Sales Engagement products comprise Marchex Engage, which combines Marchex artificial intelligence and machine learning with call monitoring and scoring services; Marchex Spotlight, a product for corporate and regional managers; Marchex Engage for Automotive; and Marchex Platform Services that allows businesses to add Marchex conversation intelligence to their existing workflows and enabling them to decode what happens in their conversations with customers. Marchex, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on Marchex in a report on Monday, August 1st. They set a "hold" rating for the company.

Marchex Stock Down 0.5 %

NASDAQ:MCHX traded down $0.01 during trading on Monday, reaching $2.04. 200 shares of the company's stock were exchanged, compared to its average volume of 29,989. The company has a 50 day moving average price of $1.72 and a two-hundred day moving average price of $1.97. Marchex has a 1 year low of $1.23 and a 1 year high of $3.63.

Marchex (NASDAQ:MCHX - Get Rating) last posted its earnings results on Thursday, May 12th. The technology company reported ($0.03) earnings per share for the quarter, beating the consensus estimate of ($0.05) by $0.02. Marchex had a negative return on equity of 8.11% and a negative net margin of 1.19%. The business had revenue of $13.17 million during the quarter, compared to the consensus estimate of $13.04 million. During the same period in the previous year, the business earned ($0.10) EPS. On average, analysts forecast that Marchex will post -0.11 earnings per share for the current fiscal year.

Receive MCHX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marchex and its competitors with MarketBeat's FREE daily newsletter.

MCHX Stock News Headlines

Marchex (MCHX) Set to Announce Earnings on Tuesday
StockNews.com Initiates Coverage on Marchex (NASDAQ:MCHX)
Reviewing Marchex (NASDAQ:MCHX) and ACV Auctions (NASDAQ:ACVA)
Marchex (NASDAQ:MCHX) Now Covered by StockNews.com
See More Headlines
Receive MCHX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Marchex and its competitors with MarketBeat's FREE daily newsletter.

MCHX Company Calendar

Last Earnings
5/12/2022
Today
8/08/2022
Next Earnings (Confirmed)
8/09/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Business services, not elsewhere classified
Sub-Industry
Internet Software & Services
Current Symbol
NASDAQ:MCHX
CUSIP
56624R10
Employees
187
Year Founded
2003

Price Target and Rating

Average Stock Price Forecast
$4.00
High Stock Price Forecast
$4.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+94.2%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-4,390,000.00
Pretax Margin
-0.84%

Debt

Sales & Book Value

Annual Sales
$53.48 million
Book Value
$1.22 per share

Miscellaneous

Free Float
34,465,000
Market Cap
$87.17 million
Optionable
Optionable
Beta
2.19

Social Links


Key Executives

  • Mr. Russell C. Horowitz (Age 55)
    Exec. Chairman & Co-CEO
    Comp: $635.22k
  • Mr. Michael A. Arends (Age 51)
    Principal Financial Officer, Principal Accounting Officer & Co-CEO
    Comp: $798.37k
  • Mr. Ryan Polley (Age 50)
    Chief Operating Officer
    Comp: $488.32k
  • Mr. John Roswech (Age 53)
    Chief Revenue Officer
    Comp: $650k
  • Mr. Todd Wilson
    VP of Strategy & Operations
  • Mr. Trevor Caldwell
    Sr. VP of Investor Relations & Strategic Initiatives
  • Ms. Michelle D'Ambrose Paterniti
    Gen. Counsel
  • Ms. Julie Warner
    Director of People Services
  • Mr. Matt Muilenburg
    Chief Market Devel. Officer
  • Dr. Junmei Zhong
    Chief AI Scientist













MCHX Stock - Frequently Asked Questions

Should I buy or sell Marchex stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Marchex in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MCHX shares.
View MCHX analyst ratings
or view top-rated stocks.

What is Marchex's stock price forecast for 2022?

1 analysts have issued 12 month price objectives for Marchex's shares. Their MCHX share price forecasts range from $4.00 to $4.00. On average, they expect the company's share price to reach $4.00 in the next year. This suggests a possible upside of 94.2% from the stock's current price.
View analysts price targets for MCHX
or view top-rated stocks among Wall Street analysts.

How has Marchex's stock price performed in 2022?

Marchex's stock was trading at $2.48 at the beginning of 2022. Since then, MCHX stock has decreased by 16.9% and is now trading at $2.06.
View the best growth stocks for 2022 here
.

When is Marchex's next earnings date?

Marchex is scheduled to release its next quarterly earnings announcement on Tuesday, August 9th 2022.
View our MCHX earnings forecast
.

How can I listen to Marchex's earnings call?

Marchex will be holding an earnings conference call on Tuesday, August 9th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Marchex's earnings last quarter?

Marchex, Inc. (NASDAQ:MCHX) issued its quarterly earnings data on Thursday, May, 12th. The technology company reported ($0.03) earnings per share for the quarter, topping the consensus estimate of ($0.05) by $0.02. The technology company earned $13.17 million during the quarter, compared to analyst estimates of $13.04 million. Marchex had a negative net margin of 1.19% and a negative trailing twelve-month return on equity of 8.11%. During the same quarter in the previous year, the firm posted ($0.10) EPS.

What is Russell Horowitz, Michael Arends, and Ethan Caldwell.'s approval rating as Marchex's CEO?

8 employees have rated Marchex Chief Executive Officer Russell Horowitz, Michael Arends, and Ethan Caldwell. on Glassdoor.com. Russell Horowitz, Michael Arends, and Ethan Caldwell. has an approval rating of 58% among the company's employees. This puts Russell Horowitz, Michael Arends, and Ethan Caldwell. in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Marchex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Marchex investors own include Onconova Therapeutics (ONTX), VBI Vaccines (VBIV), Advanced Micro Devices (AMD), Enphase Energy (ENPH), NVIDIA (NVDA), OPKO Health (OPK), Nokia Oyj (NOK), Overstock.com (OSTK), Block (SQ) and Zynga (ZNGA).

What is Marchex's stock symbol?

Marchex trades on the NASDAQ under the ticker symbol "MCHX."

How do I buy shares of Marchex?

Shares of MCHX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Marchex's stock price today?

One share of MCHX stock can currently be purchased for approximately $2.06.

How much money does Marchex make?

Marchex (NASDAQ:MCHX) has a market capitalization of $87.17 million and generates $53.48 million in revenue each year. The technology company earns $-4,390,000.00 in net income (profit) each year or ($0.02) on an earnings per share basis.

How many employees does Marchex have?

Marchex employs 187 workers across the globe.

Does Marchex have any subsidiaries?

The following companies are subsidiares of Marchex: Callcap, and Telmetrics.
Read More

When was Marchex founded?

Marchex was founded in 2003.

How can I contact Marchex?

Marchex's mailing address is 520 PIKE STREET SUITE 2000, SEATTLE WA, 98101. The official website for the company is www.marchex.com. The technology company can be reached via phone at (206) 331-3300, via email at ir@marchex.com, or via fax at 206-331-3695.

This page (NASDAQ:MCHX) was last updated on 8/9/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.